Literature DB >> 2367519

Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis.

R D Bigler1, M Khoo, S Lund-Katz, L Scerbo, M Esfahani.   

Abstract

Optimal expression of the high-affinity Fc receptor for IgG (FcRI) by the human monocyte cell line U-937 requires the presence of low density lipoprotein (LDL), and neither cholesterol nor high density lipoprotein can provide the component necessary for optimal FcRI expression. Here we show that FcR-mediated phagocytosis also requires LDL. U-937 cells were cultured in medium containing interferon gamma and either fetal calf serum (FCS) or delipidated FCS (DLFCS). The phagocytosis of IgG-coated erythrocytes was measured by a colorimetric assay. U-937 cells cultured in DLFCS medium had less than 16% of the phagocytic activity of cells cultured in normal FCS medium. Phagocytosis of IgG-coated erythrocytes could be inhibited 85% by the addition of murine IgG2a myeloma protein (5 micrograms/ml). U-937 cells cultured in DLFCS medium supplemented with pure cholesterol in ethanol (10 micrograms/ml) had only 30% of the phagocytic activity of cells grown in FCS medium. Addition of very low density lipoprotein (0.2 mg of protein per ml) to DLFCS medium also failed to increase phagocytosis. However, the addition of LDL (0.2 mg of protein per ml) to DLFCS medium restored 90% of the phagocytic activity. Since neither pure cholesterol nor very low density lipoprotein restored normal phagocytic function to U-937 cells despite a normalization of cellular cholesterol content, the restoration of phagocytosis observed with LDL replacement cannot be explained by mere delivery of cholesterol by LDL. Thus, LDL is required for the expression of FcRI and FcR-mediated phagocytosis by U-937 cells and may be an important regulator of phagocytic activity of monocytes and macrophages in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2367519      PMCID: PMC54245          DOI: 10.1073/pnas.87.13.4981

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  Structure of human serum lipoproteins inferred from compositional analysis.

Authors:  B W Shen; A M Scanu; F J Kézdy
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  Inhibition by membrane-bound low-density lipoproteins of the primary inductive events of mitogen-stimulated lymphocyte activation.

Authors:  J A Harmony; D Y Hui
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

4.  The effect of Fc fragments of IgG on human mononuclear cell responses.

Authors:  J Passwell; F S Rosen; E Merler
Journal:  Cell Immunol       Date:  1980-07-01       Impact factor: 4.868

5.  Modulation of the in vivo immune response by human plasma very low-density lipoproteins.

Authors:  F V Chisari
Journal:  Cell Immunol       Date:  1980-06       Impact factor: 4.868

6.  A requirement for cholesterol for phorbol ester-induced adhesion of a human monocyte-like cell line.

Authors:  M Esfahani; S Hathotuwegama; A Kalenak; L Scerbo; H M Brown
Journal:  Biochem Biophys Res Commun       Date:  1987-05-14       Impact factor: 3.575

7.  Human leukocyte Fc (IgG) receptors: quantitation and affinity with radiolabeled affinity cross-linked rabbit IgG.

Authors:  E L Alexander; J A Titus; D M Segal
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

8.  Immunoregulatory plasma low density lipoprotein: the biologic activity and receptor-binding specificity is independent of neutral lipids.

Authors:  L K Curtiss; T S Edgington
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

9.  Prostaglandin synthesis by macrophages requires a specific receptor-ligand interaction.

Authors:  C A Rouzer; W A Scott; J Kempe; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content.

Authors:  L K Curtiss; T S Edgington
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

View more
  9 in total

1.  Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy.

Authors:  Yoshiro Miyahara; Shinsuke Nishimura; Maho Watanabe; Kenji Ito; Hitoshi Nakashima; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2011-11-11       Impact factor: 2.801

Review 2.  In vivo clearance by the mononuclear phagocyte system in humans: an overview of methods and their interpretation.

Authors:  C Halma; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

3.  Lipoproteins modify the macrophage uptake of triacylglycerol emulsion and of zymosan particles by similar mechanisms.

Authors:  M D Carvalho; V E Tobias; C M Vendrame; A F Shimabukuro; M Gidlund; E C Quintão
Journal:  Lipids       Date:  2000-01       Impact factor: 1.880

4.  Changes in macrophage function modulated by the lipid environment.

Authors:  Michael R Williams; David M Cauvi; Isabel Rivera; Dennis Hawisher; Antonio De Maio
Journal:  Innate Immun       Date:  2016-03-07       Impact factor: 2.680

5.  Pulmonary surfactant inhibits activation of human monocytes by recombinant interferon-gamma.

Authors:  M F Geertsma; W L Teeuw; P H Nibbering; R van Furth
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

6.  Itraconazole, a commonly used antifungal, inhibits Fcγ receptor-mediated phagocytosis: alteration of Fcγ receptor glycosylation and gene expression.

Authors:  Diego F Niño; David M Cauvi; Antonio De Maio
Journal:  Shock       Date:  2014-07       Impact factor: 3.454

7.  Nutrition and lipidomic profile in colorectal cancers.

Authors:  Maria Notarnicola; Maria Gabriella Caruso; Valeria Tutino; Valentina De Nunzio; Isabella Gigante; Giampiero De Leonardis; Nicola Veronese; Ornella Rotolo; Rosa Reddavide; Elisa Stasi; Chiara Miraglia; Antonio Nouvenne; Tiziana Meschi; Gian Luigi De' Angelis; Francesco Di Mario; Gioacchino Leandro
Journal:  Acta Biomed       Date:  2018-12-17

8.  Associations of Serum Lipid Level with Gastric Cancer Risk, Pathology, and Prognosis.

Authors:  Gyu Young Pih; Eun Jeong Gong; Ji Young Choi; Min-Ju Kim; Ji Yong Ahn; Jaewon Choe; Suh Eun Bae; Hye-Sook Chang; Hee Kyong Na; Jeong Hoon Lee; Kee Wook Jung; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung
Journal:  Cancer Res Treat       Date:  2020-11-23       Impact factor: 4.679

9.  Postoperative high-density lipoprotein cholesterol level: an independent prognostic factor for gastric cancer.

Authors:  Chenxi Li; Yan Fu; Qiuwen Li; Xuhui Yang; Wenying Wang; Xin Jin; Lihua Bian; Hui Zhao; Donghui Li; Jie Gao; Nan Du; Liang Peng
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.